The use of PET imaging in Neurodegenerative Diseases
In recent years, there was a paradigm shift in the diagnosis of neurodegenerative diseases, where the clinical testing is complemented by biomarker information. PET imaging with dedicated radiopharmaceuticals provides non-invasive biomarkers and co-morbidity information, which has brought a significant impact on clinical diagnosis and patient care. Imaging the human brain can provide unique information on the pathology and progression of neurodegenerative diseases like AD and PD. Imaging is also relevant for supporting preclinical and clinical trials of new therapeutic drugs.
Watch this webinar presented by 2 leading figures of Nuclear Medicine: Dr. Rosa-Neto and Dr. Dubroff. They gave a very instructive presentation about the use of PET imaging in Neurodegenerative Diseases.